Cannon Global Investment Management LLC Invests $525,000 in Avantor, Inc. (NYSE:AVTR)

Cannon Global Investment Management LLC purchased a new stake in Avantor, Inc. (NYSE:AVTRFree Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 23,000 shares of the company’s stock, valued at approximately $525,000. Avantor accounts for approximately 3.9% of Cannon Global Investment Management LLC’s investment portfolio, making the stock its 8th biggest position.

Several other large investors have also recently added to or reduced their stakes in AVTR. Fifth Third Bancorp boosted its stake in shares of Avantor by 125.3% in the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after buying an additional 694 shares during the period. Livforsakringsbolaget Skandia Omsesidigt increased its position in shares of Avantor by 565.5% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock worth $30,000 after purchasing an additional 1,131 shares during the period. Quarry LP raised its stake in Avantor by 815.3% in the first quarter. Quarry LP now owns 1,437 shares of the company’s stock valued at $30,000 after purchasing an additional 1,280 shares in the last quarter. CKW Financial Group bought a new stake in Avantor during the fourth quarter worth about $55,000. Finally, Park Place Capital Corp grew its stake in Avantor by 18.2% during the third quarter. Park Place Capital Corp now owns 3,039 shares of the company’s stock worth $64,000 after buying an additional 467 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Avantor Trading Down 0.2 %

Shares of NYSE:AVTR traded down $0.06 during trading on Friday, reaching $24.24. The stock had a trading volume of 1,338,557 shares, compared to its average volume of 5,652,218. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.05 and a current ratio of 1.61. The firm’s fifty day moving average is $24.91 and its 200 day moving average is $22.44. Avantor, Inc. has a 52 week low of $16.63 and a 52 week high of $26.16. The stock has a market cap of $16.44 billion, a price-to-earnings ratio of 50.60, a P/E/G ratio of 1.53 and a beta of 1.37.

Avantor (NYSE:AVTRGet Free Report) last released its quarterly earnings data on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.03. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The company had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.70 billion. During the same quarter in the previous year, the business posted $0.32 EPS. Avantor’s revenue for the quarter was down 4.0% compared to the same quarter last year. As a group, equities analysts forecast that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, EVP James Bramwell sold 6,203 shares of Avantor stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total value of $151,911.47. Following the completion of the sale, the executive vice president now owns 101,143 shares of the company’s stock, valued at approximately $2,476,992.07. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.50% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on AVTR shares. Raymond James boosted their target price on shares of Avantor from $22.50 to $26.00 and gave the company an “outperform” rating in a research report on Friday, January 26th. UBS Group boosted their price objective on shares of Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. Royal Bank of Canada raised their target price on Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a report on Thursday, February 15th. Citigroup lifted their price target on Avantor from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Thursday, February 15th. Finally, Evercore ISI raised their target price on shares of Avantor from $26.00 to $28.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $26.71.

View Our Latest Stock Report on AVTR

About Avantor

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

See Also

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.